Skip to main content
Log in

Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Intracerebral hemorrhage (ICH) is the most devastating complication of oral anticoagulation (OAC). As the number of patients on long-term OAC is expected to rise, the proportion of intracerebral hemorrhage related to OAC (OAC-ICH) in relation to spontaneous ICH (spont-ICH) is expected to increase as well. We determined the proportion of OAC-ICH in consecutive stroke patients and explored differences between OAC-ICH and spont-ICH regarding initial volume, hematoma expansion and outcome. Our prospective study consecutively enrolled patients with supra- and infratentorial ICH. The National Institute of Health Stroke Scale Score and the modified Rankin Scale (mRS) score at baseline and after 3 months, medical history and demographic variables were recorded. All admission and follow-up CTs/MRIs were analysed regarding ICH volume using the ABC/2-method. Intraventricular hemorrhage (IVH) was quantified using the Graeb score. Within 19 months, 2,282 patients were admitted to our ER. 206 ICH patients were included. Overall, 24.8 % of all ICH were related to OAC. Compared to patients with spont-ICH, OAC-ICH patients were older (p = 0.001), more frequently had initial extension of ICH into the ventricles (p = 0.05) or isolated primary IVH (p = 0.03) and a higher Graeb score upon admission (p = 0.01). In contrast, initial ICH volume (p = 0.16) and ICH expansion (p = 0.9) in those receiving follow-up imaging (n = 152) did not differ between the two groups. After correction for age, there was a trend towards poorer outcome in OAC-ICH (p = 0.08). One-fourth of all ICH are related to OAC. Initial extension of ICH into the ventricles and primary IVH are more frequent in OAC-ICH. The rate of hematoma expansion in OAC-ICH patients is similar to non-anticoagulated ICH patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Connolly S (1994) Stroke prevention in atrial fibrillation II study. Lancet 343:1509

    PubMed  CAS  Google Scholar 

  2. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P et al (2007) The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68:116–121

    Article  PubMed  CAS  Google Scholar 

  3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

    Article  PubMed  CAS  Google Scholar 

  4. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992

    Article  PubMed  CAS  Google Scholar 

  5. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891

    Article  PubMed  CAS  Google Scholar 

  6. Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J (2004) Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63:1059–1064

    Article  PubMed  CAS  Google Scholar 

  7. Biffi A, Battey TW, Ayres AM, Cortellini L, Schwab K, Gilson AJ et al (2011) Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology 77:1840–1846

    Article  PubMed  CAS  Google Scholar 

  8. Steiner T, Bosel J (2010) Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke 41:402–409

    Article  PubMed  Google Scholar 

  9. Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr et al (2010) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41:2108–2129

    Article  PubMed  Google Scholar 

  10. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I et al (2006) Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22:294–316

    Article  PubMed  Google Scholar 

  11. Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W et al (2011) Paroxysmal Atrial Fibrillation Is More Prevalent than Persistent Atrial Fibrillation in Acute Stroke and Transient Ischemic Attack Patients. Cerebrovasc Dis 32:276–282

    PubMed  CAS  Google Scholar 

  12. Wilson JT, Hareendran A, Hendry A, Potter J, Bone I, Muir KW (2005) Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke 36:777–781

    Article  PubMed  Google Scholar 

  13. Rizos T, Jenetzky E, Herweh C, Unterberg A, Hacke W, Veltkamp R (2010) Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage. Neurocrit Care 13:321–325

    Article  PubMed  CAS  Google Scholar 

  14. Rizos T, Jenetzky E, Herweh C, Hug A, Hacke W, Steiner T et al (2010) Point-of-care reversal treatment in phenprocoumon-related intracerebral hemorrhage. Ann Neurol 67:788–793

    PubMed  Google Scholar 

  15. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M et al (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304–1305

    Article  PubMed  CAS  Google Scholar 

  16. Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB (1982) Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 143:91–96

    PubMed  CAS  Google Scholar 

  17. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344:1450–1460

    Article  PubMed  CAS  Google Scholar 

  18. Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26:1471–1477

    Article  PubMed  CAS  Google Scholar 

  19. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study (1998) The SPAF III Writing Committee for the stroke prevention in atrial fibrillation investigators. JAMA 279:1273–1277

    Article  Google Scholar 

  20. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119–125

    Article  PubMed  Google Scholar 

  21. Lip GY (2010) Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score = 1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. Thromb Haemost 103:683–685

    Article  PubMed  CAS  Google Scholar 

  22. Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR (2005) Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 165:1527–1532

    Article  PubMed  CAS  Google Scholar 

  23. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777–785

    Article  PubMed  CAS  Google Scholar 

  24. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:2127–2137

    Article  PubMed  CAS  Google Scholar 

  25. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T et al (2007) Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 38:1072–1075

    Article  PubMed  CAS  Google Scholar 

  26. Makris M, van Veen JJ (2011) Three or four factor prothrombin complex concentrate for emergenca anticoagulation reversal? Blood Transfus 9:117–119

    PubMed  Google Scholar 

  27. Rosand J, Eckman MH, Knudsen KA, Singer DE, Greenberg SM (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164:880–884

    Article  PubMed  CAS  Google Scholar 

  28. Franke CL, van Swieten JC, Algra A, van Gijn J (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657

    Article  PubMed  CAS  Google Scholar 

  29. Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA (2008) Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol 65:1320–1325

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Veltkamp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horstmann, S., Rizos, T., Lauseker, M. et al. Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study. J Neurol 260, 2046–2051 (2013). https://doi.org/10.1007/s00415-013-6939-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-6939-6

Keywords

Navigation